Prolonged efficacy of pembrolizumab in a patient presenting a multi-treated metastatic hepatocholangiocarcinoma

INTRODUCTION: Hepatocholangiocarcinoma (HCC-ICC) is a rare tumor presenting the histologic characteristics of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). As there is no consensus on it management, the therapeutic strategy rests on the specific treatments for HCC or...

Descripción completa

Detalles Bibliográficos
Autores principales: Saint, Angélique, Benchetrit, Maxime, Novellas, Sébastien, Ouzan, Denis, Falk, Alexander Tuan, Leysalle, Axel, Barriere, Jérome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307284/
https://www.ncbi.nlm.nih.gov/pubmed/32612680
http://dx.doi.org/10.1177/1756284820935189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307284/
https://www.ncbi.nlm.nih.gov/pubmed/32612680
http://dx.doi.org/10.1177/1756284820935189

Ejemplares similares